Literature DB >> 2534817

Inhibition of a specific DNA repair system and nitrosourea cytotoxicity in resistant human cancer cells.

B W Futscher1, K C Micetich, D M Barnes, R I Fisher, L C Erickson.   

Abstract

In this report we present evidence which suggests that pretreatment of a highly nitrosourea-resistant human colon tumor cell line with non-cytotoxic doses of streptozotocin (STZ) prior to, or simultaneously with, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) exposure produces synergistic increases in cytotoxicity of several logs over the cytotoxicity produced by exposure to BCNU alone. STZ pretreatment or simultaneous treatment with BCNU allowed BCNU-induced DNA interstrand crosslinks to form in this cell line, in which BCNU alone did not induce DNA interstrand-crosslinks. Reversal of the schedule (i.e., STZ following BCNU) was less effective in producing synergistic cell kill or increased DNA interstrand crosslinking. Replacement of BCNU with fresh BCNU was not effective in producing increased cell kill and produced no observable interstrand crosslinking. Direct assays for guanine O6-DNA alkyltransferase activity confirmed that more than 75% inhibition of this important DNA repair system occurred following exposure to 2.5 mM STZ and that the inhibition was virtually complete when STZ pretreatment was combined with BCNU exposure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2534817     DOI: 10.3727/095535489820875444

Source DB:  PubMed          Journal:  Cancer Commun        ISSN: 0955-3541


  9 in total

1.  Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene.

Authors:  G S Watts; R O Pieper; J F Costello; Y M Peng; W S Dalton; B W Futscher
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  A novel fluorometric oligonucleotide assay to measure O( 6)-methylguanine DNA methyltransferase, methylpurine DNA glycosylase, 8-oxoguanine DNA glycosylase and abasic endonuclease activities: DNA repair status in human breast carcinoma cells overexpressing methylpurine DNA glycosylase.

Authors:  E L Kreklau; M Limp-Foster; N Liu; Y Xu; M R Kelley; L C Erickson
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

3.  Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents.

Authors:  M E Dolan; R C Moschel; A E Pegg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

4.  Effect of temozolomide and dacarbazine on O6-alkylguanine-DNA alkyltransferase activity and sensitivity of human tumor cells and xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  R B Mitchell; M E Dolan
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  G M Felker; H S Friedman; M E Dolan; R C Moschel; C Schold
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

6.  The effects of O6-benzylguanine and hypoxia on the cytotoxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea in nitrosourea-resistant SF-763 cells.

Authors:  A Sarkar; M E Dolan; G G Gonzalez; L J Marton; A E Pegg; D F Deen
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  Sequential therapy with dacarbazine and carmustine: a phase I study.

Authors:  R B Mitchell; M E Dolan; L Janisch; N J Vogelzang; M J Ratain; R L Schilsky
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

8.  Methylation-related chromatin structure is associated with exclusion of transcription factors from and suppressed expression of the O-6-methylguanine DNA methyltransferase gene in human glioma cell lines.

Authors:  J F Costello; B W Futscher; R A Kroes; R O Pieper
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

9.  Cyclophosphamide decreases O6-alkylguanine-DNA alkyltransferase activity in peripheral lymphocytes of patients undergoing bone marrow transplantation.

Authors:  S M Lee; D Crowther; J H Scarffe; M Dougal; R H Elder; J A Rafferty; G P Margison
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.